Description
2026 PUBLIC LAW PRICING UPDATES.
Base award description: BPA FOR RAPIVAB, ORLADEYO
Modification chain · 10 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2021-05-18+$0= $0
- Mod P000012021-12-03+$0= $0
- Mod P000022022-04-14+$0= $0
- Mod P000032022-12-16+$0= $0
- Mod P000042023-04-17+$0= $0
- Mod P000052023-12-14+$0= $0
- Mod P000062024-04-17+$0= $0
- Mod P000072024-11-23+$0= $0
- Mod P000082025-04-14+$0= $0
- Mod P000092025-12-08+$0= $0
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2021-05-18 | +$0 | $0 | BPA FOR RAPIVAB, ORLADEYO |
| Mod P00001· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2021-12-03 | +$0 | $0 | 2022 PUBLIC LAW UPDATES |
| Mod P00002· EXERCISE AN OPTION | 2022-04-14 | +$0 | $0 | EXERCISE OPTION YEAR 1. |
| Mod P00003· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2022-12-16 | +$0 | $0 | 2023 PUBLIC LAW PRICING UPDATES |
| Mod P00004· EXERCISE AN OPTION | 2023-04-17 | +$0 | $0 | EXERCISE OPTION YEAR 2 - BPA 36E79721A0015 |
| Mod P00005· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2023-12-14 | +$0 | $0 | 2024 PUBLIC LAW PRICING UPDATES |
| Mod P00006· EXERCISE AN OPTION | 2024-04-17 | +$0 | $0 | EXERCISE OPTION YEAR 3 |
| Mod P00007· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2024-11-23 | +$0 | $0 | 2025 PUBLIC LAW PRICING UPDATES |
| Mod P00008· EXERCISE AN OPTION | 2025-04-14 | +$0 | $0 | EXERCISE THE 4TH AND FINAL OPTION YEAR |
| Mod P00009· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2025-12-08 | +$0 | $0 | 2026 PUBLIC LAW PRICING UPDATES. |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI MGXADJ6SCLJ5)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36E79726A0015 | NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2026 |
| 36C24926F0152 | 249-NETWORK CONTRACT OFFICE 9 (36C249) · 6505 · DRUGS AND BIOLOGICALS | $30,293 | FY2026 |
| 36C26026F0294 | 260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS | $151,465 | FY2026 |
| 36C26026F0006 | 260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS | $360,000 | FY2026 |
| 36C26025F0296 | 260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS | $29,408 | FY2025 |
| 36C26025F0070 | 260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS | $242,987 | FY2025 |
Other recipients under 6505 from NAC PHARMACEUTICALS (36E797) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36E79726A0025 | CHIESI USA INC | NAC PHARMACEUTICALS (36E797) | $0 | FY2026 |
| 36E79726A0024 | NEUROTECH PHARMACEUTICALS, INC | NAC PHARMACEUTICALS (36E797) | $0 | FY2026 |
| 36E79726A0023 | TAKEDA PHARMACEUTICALS AMERICA, INC. | NAC PHARMACEUTICALS (36E797) | $0 | FY2026 |
| 36E79726D0041 | GOLDEN STATE MEDICAL SUPPLY, INC. | NAC PHARMACEUTICALS (36E797) | $0 | FY2026 |
| 36E79726A0022 | AURINIA PHARMA US INC | NAC PHARMACEUTICALS (36E797) | $0 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_IDV_36E79721A0015_3600 · retrieved 2026-09-26.